Zynerba Pharmaceuticals I... (ZYNE)
NASDAQ: ZYNE
· Real-Time Price · USD
1.30
0.03 (2.36%)
At close: Oct 10, 2023, 10:00 PM
Zynerba Pharmaceuticals Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -10.78M | -10.11M | -8.02M | -8.68M | -9.85M | -8.49M | -8.82M | -10.58M | -9.95M | -7.96M |
Depreciation & Amortization | 65.69K | 51.64K | 53.36K | 51.19K | 54.03K | 60.7K | 61.9K | 61.9K | 61.9K | 61.45K |
Stock-Based Compensation | 768.58K | 821.99K | 1.02M | 1.04M | 1.11M | 1.16M | 1.04M | 1.57M | 1.93M | 1.26M |
Other Working Capital | 1.21M | 1.09M | 928.49K | -2.02M | 749.84K | 7.73M | 714.81K | -2M | 605.47K | -798.11K |
Other Non-Cash Items | n/a | n/a | 7.46M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Deferred Income Tax | n/a | n/a | -7.46M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | 1.52M | 1.36M | 1.26M | -2.07M | 806.79K | 7.47M | -122.73K | -1.1M | 670K | -1.66M |
Operating Cash Flow | -8.42M | -7.88M | -5.69M | -9.66M | -7.88M | 200.63K | -7.83M | -10.05M | -7.28M | -8.29M |
Capital Expenditures | -8.4K | -89.55K | -7.4K | -95.1K | n/a | -51.61K | n/a | n/a | -47.57K | n/a |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Investing Cash Flow | -8.4K | -89.55K | -7.4K | -95.1K | n/a | -51.61K | n/a | n/a | -47.57K | n/a |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | -6.71K | 1.73M | 399.35K | 3.2M | 675.41K | 1.74M | n/a | -92.03K | -18.08K | 42.27M |
Financial Cash Flow | -6.71K | 1.73M | 399.35K | 3.2M | 675.41K | 1.74M | n/a | -92.03K | -18.08K | 42.27M |
Net Cash Flow | -8.43M | -6.24M | -5.29M | -6.56M | -7.21M | 1.89M | -7.83M | -10.14M | -7.35M | 33.97M |
Free Cash Flow | -8.43M | -7.97M | -5.69M | -9.75M | -7.88M | 149.03K | -7.83M | -10.05M | -7.33M | -8.29M |